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ABSTRACT 24 
Multi-scale epidemic forecasting models have been used to inform population-scale 25 
predictions with within-host models and/or infection data collected in longitudinal cohort 26 
studies. However, most multi-scale models are complex and require significant modelling 27 
expertise to run. We formulate an alternative multi-scale modelling framework using a 28 
compartmental model with multiple infected stages. In the large-compartment limit, our 29 
easy-to-use framework generates identical results compared to previous more 30 
complicated approaches. We apply our framework to the case study of influenza A in 31 
humans. By using a viral dynamics model to generate synthetic patient-level data, we 32 
explore the effects of limited and inaccurate patient data on the accuracy of population-33 
scale forecasts. If infection data are collected daily, we find that a cohort of at least 40 34 
patients is required for a mean population-scale forecasting error below 10%. Forecasting 35 
errors may be reduced by including more patients in future cohort studies or by increasing 36 
the frequency of observations for each patient. Our work therefore provides not only an 37 
accessible epidemiological modelling framework, but also insight into the data required 38 
for accurate forecasting using multi-scale models. 39 
KEYWORDS 40 
epidemiological model; infectious disease outbreak forecasting; multi-scale model; 41 
nested model; longitudinal study; cohort study 42 
 43 
1. INTRODUCTION 44 
Infectious disease epidemics in humans, animals and plants have severe impacts [1–7]. 45 
Mathematical models are increasingly used to forecast the future dynamics of outbreaks 46 
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[7–9] and to plan interventions [10–13], while within-host models are used to understand 47 
the spread of infection at the individual host-level [14–17]. Standard population-scale 48 
epidemiological models assume that the infectiousness of each host is constant over 49 
the course of the infectious period [4], but in reality infectiousness will vary as the 50 
infection progresses through the host due to changing pathogen loads [18,19] and other 51 
factors including behavioural responses to infection [18,20]. 52 
 53 
Multi-scale models have been used to connect epidemiological dynamics at the patient-54 
level (within-host; we refer to “patients” throughout but similar ideas can be applied to 55 
pathogens of animals or plants) to those at the population-scale (between-host) [21–34]. 56 
These models (sometimes referred to as nested models [19,30]) tend to assume a 57 
specified relationship between the level of infection within a patient and the rate at 58 
which the patient transmits the pathogen to susceptible individuals [18,19,35]. A within-59 
host model, parameterised by fitting to patient data, is then used to determine the 60 
parameters of a population-scale model incorporating time-dependent infectiousness 61 
[19,35]. In addition to patient-level dynamics affecting population-scale transmission, 62 
there may be reciprocal feedback from the population-scale to the patient-level [19] – for 63 
example, if there are multiple co-circulating strains of the pathogen [24]. 64 
 65 
A recent review concluded that, while numerous multi-scale epidemiological modelling 66 
studies exist, relatively few include substantial use of data [29]. While one reason for 67 
this is the lack of widely available datasets [18,36], we contend that another contributing 68 
factor is that previous multi-scale modelling frameworks have been complex, making 69 
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them challenging to implement other than by highly specialist mathematical modellers. 70 
Such frameworks have often employed integro-differential equations (IDEs) 71 
[19,24,27,30,31,33,35,37], although alternatives such as individual-based stochastic 72 
models [12,23,25,26,38] have also been considered. IDEs are challenging to solve, 73 
requiring bespoke numerical methods [28]. Some studies using IDEs have involved 74 
explicit simulation of the full multi-scale model [24,31,37]. However, others have either 75 
only used the multi-scale framework to derive quantities such as the basic reproduction 76 
number of the pathogen rather than predicting temporal epidemic dynamics [30,33], or 77 
have made simplifying assumptions such as taking a within-host model to be in 78 
equilibrium [21,22,27,32]. Although an assumption that the pathogen load in each 79 
infected host is not changing (or changes only a limited number of times) might be 80 
appropriate for chronic infections, it leads to an approximate population-scale model 81 
that does not explicitly account for time-dependent infectiousness or other potentially 82 
complex patient-level dynamics. 83 
 84 
In most previous studies that have used IDEs to transition from within- to between-host, 85 
the progression of infection through all patients has been assumed to be identical [35]. 86 
Patient-level dynamics are therefore characterised by a within-host model in which the 87 
values of model parameters (describing factors such as pathogen replication as well as 88 
immune responses) are the same for all patients. These parameters have either 89 
assumed values that have not been derived rigorously from data [29], or have been 90 
obtained by fitting the model to data collected in longitudinal cohort studies from a small 91 
number of patients [27,33]. Within-host parameters are, in fact, likely to vary between 92 
5 
 
individuals [14,39,40], for example due to differences in immune responses [41], while 93 
measurement error may also lead to inaccurate parameter estimates particularly given 94 
limited numbers of observations [35,42]. As we show, if patient-level data are only 95 
available from a limited number of patients, then predictions of population-scale 96 
epidemic dynamics may be inaccurate. 97 
 98 
In this paper, we introduce a novel framework for transitioning from within- to between-99 
host epidemiological dynamics straightforwardly. Our method involves using a 100 
compartmental model with a large number of infected compartments to predict the 101 
population-scale dynamics. Compartmental models, comprising systems of ordinary 102 
differential equations (ODEs), can be solved easily using standard numerical routines 103 
and software packages [4,28,43,44], are straightforward to adapt to include further 104 
biological detail [4,20,28], and are widely used for epidemic modelling [4,45]. We show 105 
rigorously that our modelling framework is equivalent to a more complex IDE approach, 106 
in the large-compartment limit of our method. Since the number of compartments is 107 
simply a choice for the user to make, our easy-to-use method can generate results that 108 
are as accurate as those from more complex approaches. 109 
 110 
To demonstrate our framework, we consider modelling an outbreak due to the influenza 111 
A virus. We use a previously parameterised within-host model [14] to generate a 112 
synthetic dataset representative of real patient data (figure S1), incorporating variability 113 
in the viral load time series between patients due to factors such as differences in 114 
immune responses. Since the magnitude of this variability has been chosen to match 115 
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data from a previous cohort study [14,46], our dataset is comparable to obtaining data 116 
from a cohort study, but with the advantage that we can test our approach using many 117 
different possible cohorts of any size (from small cohort sizes up to very large cohort 118 
sizes that generate idealised data). We explore the effects of both the number of 119 
patients from which data are available, and the extent of measurement error in patient 120 
data, on population-scale predictions. Our work therefore provides insight into the data 121 
required for accurate forecasting using multi-scale epidemic models, as well as an 122 
accessible modelling framework that can be used for forecasting during future 123 
epidemics of a range of infectious diseases. 124 
 125 
2. RESULTS 126 
Transitioning from within- to between-host influenza dynamics 127 
 128 
We have developed a new compartmental framework for transitioning from within- to 129 
between-host epidemic dynamics. In our approach, a within-host model is fitted to data 130 
from individual patients, to estimate the pathogen load of each measured patient at 131 
every time since infection (figure 1a). As with other multi-scale epidemic models 132 
[18,19,35], by assuming a functional relationship between pathogen load and 133 
infectiousness, the expected infectiousness, 𝛽(𝜏), of any host is then estimated at each 134 
time since infection, 𝜏 days (figure 1b). We will call 𝛽(𝜏) the expected infectiousness 135 
curve. In previous approaches, the Kermack and McKendrick (K&M) IDE model [47] 136 
(see Section S1 of the Supplementary Material) has then been used to calculate the 137 
population-scale dynamics (figure 1c). We instead use the expected infectiousness 138 
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curve to parameterise a multi-stage compartmental model with a large number of 139 
infected compartments (figure 1d), which can also be used to predict the population-140 
scale dynamics (figure 1e). For details on the compartmental and IDE approaches, see 141 
Methods. In the limit of infinitely many compartments in our framework, the two 142 
approaches are mathematically equivalent (we prove this rigorously in Section S2). 143 
 144 
 145 
Figure 1. Schematic demonstrating methods for transitioning from patient-level to population-146 
scale epidemiological dynamics. In standard approaches (a-c), measurements from within each patient 147 
(a) are used to parameterise a within-host model, giving rise to an averaged infectiousness curve (b). 148 
These patient-level dynamics can then be nested in an IDE model (e.g. the K&M model [47]) used to 149 
predict the population-scale dynamics (c). However, IDE models are challenging to solve. In contrast, in 150 
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our approach (a,b,d,e) the expected infectiousness curve is instead used to parameterise a 151 
compartmental model (d) that can be used to predict population-scale dynamics straightforwardly (e). 152 
Early-epidemic oscillations in panels (c) and (e) occur because the expected infectiousness of an infected 153 
host is close to zero in the first day of infection, leading to delays before successive generations of newly 154 
infected hosts begin to transmit the pathogen. 155 
 156 
To illustrate our framework in a concrete setting, we considered the specific case of 157 
influenza A infection in humans. We used the target cell-limited (TCL) within-host 158 
model, which has previously been fitted to data from a cohort study of influenza 159 
infection [14], to generate synthetic data from a large number of patients (see Methods). 160 
The data were used to calculate the expected infectiousness curve (figure 2a) under the 161 
assumptions of a linear relationship between viral load and infectiousness 162 
[18,33,35,38,39] and a basic reproduction number (defined to be the expected number 163 
of secondary cases arising from a single infected host in an otherwise entirely 164 
susceptible population [4]) of 1.5 [8] (see Methods), although we consider other 165 
assumptions and values of the reproduction number later (Sections S8 and S9). 166 
 167 
Both our compartmental approach using a large number of infected compartments (n = 168 
1000) and the previously used IDE method (i.e. the K&M model) were then used to 169 
predict the population-scale outbreak dynamics, initially assuming the expected 170 
infectiousness curve was known exactly (figure 2b). We considered a population of size 171 
N = 1000 and assumed a single newly infected individual was introduced into an entirely 172 
susceptible population. The two approaches produced almost identical results – the 173 
error in the predicted population-scale dynamics when the compartmental method was 174 
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used, calculated as a proportional error relative to the dynamics predicted using the IDE 175 
method (see Methods), was only 0.2%. We explored how many compartments are 176 
required in our framework to ensure accurate population-scale forecasts, finding that in 177 
general, the error in predictions scales with 1/n as the number of compartments, n, 178 
becomes large (Section S5). When the infectiousness curve shown in figure 2a was 179 
used to transition to population-scale dynamics, we found that n = 24 compartments are 180 
sufficient for an error in population-scale predictions of 10% or less (figure S2b). 181 
 182 
 183 
Figure 2. Transitioning from within- to between-host influenza dynamics using the compartmental 184 
and IDE methods. (a) The expected infectiousness curve, 𝛽(𝜏), when the patient-level dynamics are 185 
perfectly characterised. (b) The population-scale dynamics, using our compartmental approach with n = 186 
1000 infected compartments (blue), and using the IDE method (black dashed), for the infectiousness 187 
curve shown in panel (a). 188 
 189 
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The effect of limited and inaccurate patient-level data on population-scale 190 
predictions 191 
 192 
We considered the effect of two quantities on population-scale predictions: the number 193 
of patients from which individual patient data are available, and the extent of 194 
measurement error in patient-level data. Initially, we considered these two factors in 195 
isolation, before testing their combined effects. We defined error metrics to quantify the 196 
errors that arose in the patient-level dynamics (the within-host error) and in the 197 
population-scale dynamics (the between-host error), using proportional errors in order to 198 
enable comparison between errors at the two scales (see Methods). 199 
 200 
Number of patients 201 
 202 
In most cohort studies used to inform multi-scale models, data are only available from a 203 
small number of patients [27,33] and within-host parameters may vary significantly 204 
between patients [14,39,40]. To investigate the error in population-scale predictions that 205 
inadequate data may generate, we supposed that data were only available from d 206 
randomly chosen patients (see Methods). To isolate the effect of variability between 207 
hosts rather than measurement error, the exact viral load of each patient was initially 208 
assumed to be known at every time since infection. We used the available data to 209 
estimate the expected infectiousness curve (figure 3a) and calculated the approximate 210 
population-scale dynamics using our compartmental framework with n = 1000 infected 211 
compartments (figure 3b). For a fixed cohort size, d, significantly different predictions of 212 
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population-scale dynamics are possible, depending on which patients are included in 213 
the study (figure 3c). Therefore, we calculated the distributions of errors in both the 214 
patient-level and population-scale dynamics, relative to the case in which the patient-215 
level dynamics were perfectly characterised, over 5000 repeats for each of a range of 216 
patient cohort sizes, d (figure 3d). Equivalent results using the IDE method rather than 217 
our compartmental approach are shown in figure S3a. 218 
 219 
 220 
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Figure 3. How many patients need to supply data for accurate population-scale predictions? (a) 221 
Examples of approximate expected infectiousness curves when (exact and continuous) data are available 222 
from d = 1 (green), d = 10 (blue) or d = 20 (red) randomly chosen patients, and the expected 223 
infectiousness curve when the patient-level dynamics are perfectly characterised (black dotted). (b) The 224 
predicted population-scale dynamics for each infectiousness curve in panel (a), using n = 1000 225 
compartments in our framework. (c) Three examples of possible approximate population-scale dynamics, 226 
when data are available from d = 10 patients. (d) Box-and-whisker plots indicating the distributions of 227 
within-host (black) and between-host (blue) errors for different groups of patients randomly chosen in the 228 
study cohort, for a range of values of the number of patients, d.  The boxes indicate the lower quartile, 229 
median and upper quartile, and the maximum length of each whisker is 1.5 times the interquartile range. 230 
The crosses represent the between-host errors corresponding to the curves of the same colour in panel 231 
(c) (these are at values of 28%, 17% and 5% error). 232 
 233 
As the number of patients is increased, the errors at patient-level and population-scale 234 
both decrease in general (depending on precisely which patients are included in the 235 
study cohort), but at a decreasing rate. The magnitude of the population-scale error is 236 
generally smaller than that of the patient-level error. Therefore, limited data do not 237 
necessarily preclude accurate population-scale predictions, even when there is a large 238 
amount of variability between different patients. In this case – when there are exact and 239 
continuous data available from each patient – a cohort size of d = 20 patients is 240 
sufficient for the between-host error to be 10% or less on average (figure 3d). However, 241 
since the errors are affected by the precise patients included in the cohort, more 242 
patients are required for a greater certainty of a small between-host error. For example, 243 
d = 30 patients are required to ensure that the upper quartile of between-host errors for 244 
cohorts of that size is less than 10%. 245 
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 246 
Extent of measurement error 247 
 248 
In longitudinal cohort studies, data are only collected from each patient at a limited 249 
number of time points. For studies of influenza infections, data may be collected daily 250 
(for example [14,39]) over the course of infection, which lasts approximately one week 251 
[48]. However, there can be significant measurement error whenever the viral load is 252 
recorded [35,42]. 253 
 254 
We considered viral load values recorded daily for each patient for a week after 255 
infection, although we also considered the effect of more frequent observations (Section 256 
S7). To incorporate measurement error in the synthetic data, a normally distributed error 257 
with standard deviation 𝜎 was applied to the logarithm of each measurement. To 258 
estimate the patient-level dynamics, we fitted the TCL model to the data for each patient 259 
(figure 4a, see Methods for details). 260 
 261 
To demonstrate the effect of measurement error on population-scale predictions, we 262 
assumed that data were available from d = 10 randomly chosen patients, and compared 263 
estimates of the expected infectiousness curve, first under the assumption that the viral 264 
load of each host was known exactly at all times during infection, and second when 265 
there was measurement error in daily recordings of the viral load (figure 4b). Our 266 
compartmental framework with n = 1000 compartments was then used to predict the 267 
population-scale dynamics in both cases (figure 4c). We calculated the within-host and 268 
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between-host errors that arose directly due to measurement error, by taking the “true” 269 
dynamics to be those when exact and continuous data were available from the same 10 270 
hosts. The distributions of these errors, each time calculated over 5000 repeats for a 271 
range of values of 𝜎, are shown in figure 4d (for equivalent results obtained using the 272 
IDE method, see figure S3b). 273 
 274 
 275 
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Figure 4. The effect on population-scale predictions of measurement error in patient-level data. (a) 276 
Example of synthetic data for a single patient: the true viral load of the patient against time since infection 277 
(blue), daily synthetic data with a measurement noise level of 𝜎 = 1 log10(TCID50/ml) (red crosses), and 278 
the viral load against time when the TCL model is fitted to the data (green). In figure S1, synthetic viral 279 
load data generated using the TCL model are compared to the real data that were used to parameterise 280 
the TCL model [14]. (b) Examples of expected infectiousness curves, without measurement error (blue) 281 
and with measurement error (green), for d = 10 patients. (c) The population-scale dynamics for each 282 
infectiousness curve in (b), using n = 1000 compartments in our framework. (d) Box-and-whisker plots 283 
indicating the distributions of within-host (black) and between-host (blue) errors arising directly due to 284 
measurement error, for a range of values of the extent of measurement error, 𝜎. The red crosses 285 
represent the within-host error corresponding to panel (b) and the between-host error corresponding to 286 
panel (c) (these are at values of 21% and 17% error, respectively). 287 
 288 
The errors at patient-level and at population-scale both increase with the measurement 289 
noise level, 𝜎. For values of 𝜎 of 1 log10(TCID50/ml) or higher, the mean population-scale 290 
error is over 10%. In that case, when a cohort of only d = 10 patients is used, 291 
measurement error alone is likely to prevent accurate population-scale forecasts, even if 292 
there is no additional error contribution due to within-host parameter variability. 293 
 294 
Overall error 295 
 296 
So far, we have described our analyses considering the separate effects of patient 297 
cohort size and measurement noise on the characterisation of within-host viral load time 298 
series, as well as the resulting impact on population-scale outbreak predictions. 299 
However, in reality, both these sources of error would be present simultaneously. Errors 300 
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would also occur if a small number of compartments is used in our multi-scale modelling 301 
approach, although this can be avoided by simply choosing a large number of 302 
compartments in the model. Nonetheless, we also conducted an analysis in which all 303 
three potential sources of error were included: (i) number of patients; (ii) measurement 304 
error; (iii) number of compartments.  305 
 306 
When we investigated the combined effect of these potential sources of error, we 307 
considered a measurement noise level of 𝜎 = 1 log10(TCID50/ml), since this generated 308 
synthetic data comparable to those recorded in cohort studies (figure S1). Assuming 309 
that data were available from d randomly sampled patients, our compartmental 310 
framework with n infected compartments was used to estimate the population-scale 311 
dynamics. We repeated this analysis 10,000 times each for different pairs of values of d 312 
and n, each time calculating the within-host and between-host errors, relative to the 313 
case in which the patient-level dynamics were perfectly characterised and the IDE 314 
method was used (equivalent to using infinitely many compartments in our 315 
compartmental framework). The distributions of within-host and between-host errors, 316 
when a large number of compartments (n = 1000) is used in our framework, are plotted 317 
for different numbers of patients (d) in figure 5a. Equivalent results using the IDE 318 
method are shown in figure S3c. When either the compartmental or IDE approach is 319 
used, data from d = 40 patients are required for an average between-host error of 10% 320 
or below (compared to 20 patients if data are recorded exactly, i.e. with no 321 
measurement error – see figure 3d and figure S3a).  322 
 323 
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 324 
Figure 5. The effects of the number of patients and number of compartments on population-scale 325 
predictions. (a) Box-and-whisker plots indicating the distributions of within-host (black) and between-host 326 
(blue) errors for different patients chosen in the study cohort when n = 1000 compartments are used in 327 
our framework, assuming a measurement noise level of 𝜎 = 1 log10(TCID50/ml), for a range of values of 328 
the number of patients, d. (b) The expected error in the population-scale dynamics, for different values of 329 
the number of compartments, n, and the number of patients, d. The red line indicates where the error is 330 
10%. 331 
 332 
The mean error in the population-scale dynamics, for different numbers of patients (d) 333 
and numbers of compartments (n), is shown in figure 5b. In the case of d = 40 patients, 334 
each sampled once daily, the user should choose at least n = 60 compartments in our 335 
approach to ensure a mean error of 10% or less. As few as 40 compartments are 336 
needed if data are available from a large number (more than 60) of patients. 337 
Nonetheless, since the number of compartments to use is simply a choice for the user – 338 
rather than requiring any more data to be collected – we suggest that any user of our 339 
framework simply chooses a very large number of compartments. We note, however, 340 
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that the benefit of using more compartments becomes negligible when more than n = 341 
100 compartments are included in our approach (figure 5b). 342 
 343 
Whereas in figure 5 we assumed data were collected once daily for a week from each 344 
patient, we also conducted supplementary analyses of the between-host error when 345 
data were instead collected twice per day from each patient (Section S7) – in this case, 346 
data are only required from 20 patients for a mean between-host error of 10% or less 347 
(figure S4b). If instead the total number of measurements that can be taken is fixed, 348 
then it might be necessary to choose between sampling a large number of patients 349 
infrequently, or a small number of patients frequently. We explored this in Section S7, 350 
and found that sampling patients more than twice per day tended to lead to less 351 
accurate population-scale predictions when the total number of measurements was 352 
fixed at values below 1000 (figure S5). For realistic cohort sizes, population-scale errors 353 
were similar when data were collected either once daily from 2d patients or twice daily 354 
from d patients (for example, when d = 20, the respective errors are both 10%). 355 
 356 
We examined the robustness of our results to our assumptions when transitioning from 357 
within- to between-host (Section S8), finding similar results to those shown in figure 5 in 358 
two alternative cases, in which the infectiousness of each patient either scales with the 359 
logarithm of their viral load (figure S6c) or saturates at high viral loads (figure S6f). In 360 
addition, we considered the effect of the assumed value of the basic reproduction 361 
number, R0, on our results (Section S9), and also repeated our analyses in figure 5 for 362 
different values of the measurement noise level, 𝜎 (Section S10), and for different levels 363 
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of variability in the within-host parameter values corresponding to different patients 364 
(Section S11). When R0, 𝜎, or the level of variability in within-host parameter values, 365 
exceeded the values considered in figure 5, a cohort size larger than 40 hosts was 366 
found to be required to ensure a mean between-host error of 10% or below (figures S7-367 
S9) – for example, data from 70 patients are required if R0 = 3 (figure S7i). 368 
 369 
3. DISCUSSION 370 
In this article, we have introduced a novel, easy-to-use, compartmental framework for 371 
nesting patient-level data in population-scale epidemic models. In the large-372 
compartment limit, our method is mathematically equivalent to more complicated 373 
approaches that involve IDEs (Section S2). However, our method has the advantage 374 
that it can be used straightforwardly, allowing it to be applied widely in future. We have 375 
provided adaptable computing code alongside this article to facilitate future use of our 376 
approach (see Data Accessibility). 377 
 378 
To illustrate our method, we considered the example of influenza A infection in humans. 379 
A viral dynamics model [14] was used to generate a synthetic dataset describing 380 
changing viral loads in a cohort of patients, which is representative of real patient data 381 
(figure S1). We showed how our compartmental framework can be used to predict the 382 
population-scale epidemic dynamics, and compared our predictions to forecasts using 383 
the more complicated K&M IDE model. The population-scale predictions from our 384 
framework closely matched those obtained using the IDE model, provided that a 385 
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sufficient number of compartments was employed in our approach (figure 2b and figure 386 
S2). 387 
 388 
The amount of data used in modelling studies of within-host influenza dynamics has 389 
varied widely, with some studies using data from fewer than 10 patients [14] but others 390 
more than 40 patients [39]. While multi-scale models have often been parameterised 391 
using either no or limited data [29], drawing robust population-scale conclusions from 392 
cohort studies involving a small number of patients is likely to be challenging, since 393 
patient-level dynamics display significant variability between different individuals 394 
[14,39,40]. We therefore assessed the errors that arise in predicted population-scale 395 
dynamics as a result of limited patient data, as well as considering measurement errors 396 
that can beset parameter inference from patient-level data [42]. We first investigated 397 
these effects separately (figures 3 and 4), before considering both these effects in a 398 
single combined analysis (figure 5). When patient data were collected once daily, we 399 
found that data from at least 40 patients were required for a mean population-scale 400 
error of 10% or smaller when either our compartmental approach or the IDE method 401 
was used (figure 5a and figure S3c). However, since the precise value of the 402 
population-scale error depended on the exact subset of patients that was included in the 403 
study, the error could be either larger or smaller than 10% even when data were 404 
available from 40 patients (figure 5a). As a result, larger numbers of patients can 405 
increase the confidence that the error is below a pre-specified threshold value (figure 406 
5a). We considered daily measurements of pathogen load, since this frequency of data 407 
acquisition is common to a number of previous longitudinal studies of influenza 408 
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infections (e.g. [14,39]). However, the accuracy of population-scale predictions depends 409 
on the frequency with which data are collected (Section S7), so ensuring regular data 410 
collection from each patient in future cohort studies is important for accurate population-411 
scale forecasting. 412 
 413 
Our approach was motivated by earlier studies in which compartmental models with 414 
multiple latent and infectious stages were employed so that the standard assumption of 415 
exponentially distributed latent and infectious periods was relaxed [49–53]. The use of 416 
multiple stages allows for gamma distributed latent and infectious periods (the so-called 417 
“linear chain trick” [52] or “method of stages” [53]), and gamma distributions have been 418 
shown to characterise epidemiological periods accurately [49,51]. However, in those 419 
studies [49–53], the level of infectiousness is assumed constant throughout the 420 
infectious period. We were therefore also inspired by previous research in which time-421 
dependent infectiousness was incorporated into multi-stage compartmental models, in 422 
cases where the compartments correspond to clearly distinct phases of infection (for 423 
example, studies of HIV [54] and Ebola [20]) or convenient time periods [55]. Our 424 
approach is more similar to a method used to include experimental data in models of 425 
plant disease [28], but differs from previous literature [20,28,54,55] due to our use of a 426 
large number of infected compartments corresponding to different infection rates in 427 
order to provide an easy method to transition from within- to between-host that is 428 
accurate for any patient-level infection dynamics. 429 
 430 
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We focussed on the case study of influenza A in humans because compartmental 431 
models are frequently used to model both patient-level and population-scale influenza 432 
dynamics, while there has also been significant interest in developing models linking the 433 
dynamics at the two scales [35]. In principle, however, our approach could be extended 434 
to model outbreaks of a range of other pathogens for which patient-level dynamics are 435 
well characterised. This would require careful consideration of the functional relationship 436 
between pathogen load and infectiousness, since this is likely to differ between 437 
pathogens [18]. In particular, the mode of transmission may be an important factor in 438 
determining suitable relationships for different pathogens. 439 
 440 
To describe individual patient-level influenza dynamics, we used the simple TCL within-441 
host model. More detailed within-host models exist, and involve features including a 442 
delay before target cells begin to shed virus (an eclipse phase) [14] or explicit modelling 443 
of innate and adaptive immune responses [56]. While the TCL model was sufficient to 444 
demonstrate our approach here, the expected infectiousness curve in our framework 445 
could be generated using a within-host model with any level of complexity. Alternatively, 446 
if patient-level infection dynamics are not well characterised, then an expected 447 
infectiousness curve that is estimated from transmission data [12,57], rather than within-448 
host data, could also be embedded within our framework. 449 
 450 
In order to generate synthetic patient-level data, we assumed that two within-host 451 
parameters varied between patients, using previous parameter estimates to determine 452 
the level of parameter variability [14]. We incorporated measurement error by adding a 453 
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normally distributed random variate to daily observations of the logarithm of the viral 454 
load (although we also considered other frequencies of data collection in Section S7). 455 
Differences in both the extent of measurement error, and the extent of parameter 456 
variability between patients, can lead to significant differences in population-scale errors 457 
(figures S8 and S9). Therefore, when our modelling framework is used to determine 458 
how many patients should be included in future cohort studies, careful consideration of 459 
the measurement error and the variability in pathogen load time series between patients 460 
is important. 461 
 462 
The TCL model was fitted to the data from each patient using a basic least squares 463 
estimation approach, since the precise method of parameter inference is not central to 464 
our modelling framework. However, it would be straightforward to extend our approach 465 
to consider different error structures and methods for fitting models to patient-level data. 466 
In particular, a non-linear mixed effects modelling approach – amounting to a partial 467 
pooling of the data between individuals – could be used. This would enable robust 468 
parameter estimation in a real dataset, particularly in settings in which the numbers of 469 
data points per patient are small, and both the frequency and timing of data collection 470 
may vary between patients [58,59]. Going forward, we will use such a method to explore 471 
further whether or not there is an optimal balance between the number of patients and 472 
the frequency of measurements per patient, if total resources are limited (see Section 473 
S7). 474 
 475 
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In our main analyses, we made the common assumption that the infectiousness of an 476 
influenza-infected host is proportional to their viral load [18,33,35,38,39], although we 477 
also obtained similar results in two alternative cases in which infectiousness either 478 
scales with the logarithm of the viral load [33,38] or saturates at high pathogen loads 479 
[21,55] (Section S8). However, more complex possibilities could easily be incorporated 480 
into our framework. For example, future studies may also incorporate varying symptoms 481 
during infection into our approach [20,23,39], in order to account for dependency of 482 
transmissibility on behavioural factors in addition to pathogen load [18]. 483 
 484 
While we considered errors in population-scale predictions arising due to variability 485 
between different infected patients when data are limited, our results were obtained 486 
using a population-scale model in which the population was assumed to be 487 
homogeneous and well-mixed. Variability between different patients was assumed to be 488 
random, so that all infected hosts could effectively be assumed to follow the same 489 
averaged infectiousness curve. In Section S3, we provide mathematical justification for 490 
this averaging in the population-scale dynamics (see also [60]). We sought to develop 491 
our framework for transitioning from within- to between-host using the simplest possible 492 
population-scale model, but our compartmental approach could be generalised, for 493 
example, to models incorporating age structure, spatial effects, social contact networks 494 
or stochasticity [4]. In an age-structured model, different within-host parameter values 495 
(or even different models) could be used to describe patient-level dynamics in the 496 
different age groups, since there may be substantial differences in within-host dynamics 497 
between patients of different ages [61]. 498 
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 499 
In summary, we have introduced a novel compartmental framework for nesting patient 500 
data in population-scale epidemiological models. We have demonstrated our easy-to-501 
use approach in the context of influenza. Not only can our modelling approach be used 502 
to inform population-scale predictions with data from patients, but it can also be used to 503 
design cohort studies by determining which data need to be collected. As a result, clear 504 
communication between clinical epidemiologists who conduct cohort studies and 505 
epidemiological modellers will allow for optimal study design. Including patient-level 506 
dynamics in population-scale epidemiological models as proposed here has the 507 
potential to improve epidemic forecasts; we hope that the simplicity of our approach will 508 
facilitate its use for forecasting in a wide range of future outbreaks. 509 
 510 
4. METHODS 511 
Within-host model 512 
 513 
The TCL model of viral dynamics, which has previously been used to model influenza 514 
infections [14,15,62], is given by 515 𝑑𝑇𝑑𝜏 = −𝛽𝑇𝑉, 𝑑𝐼𝑑𝜏 = 𝛽𝑇𝑉 − 𝛿𝐼, 𝑑𝑉𝑑𝜏 = 𝑝𝐼 − 𝑐𝑉, (4.1) 
where T(𝜏) is the number of susceptible target cells, I(𝜏) is the number of infected target 516 
cells, V(𝜏) TCID50/ml is the quantity of free virus, and 𝜏 days is the time since infection. 517 
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The model has previously been parametrised [14] for influenza A infection in humans 518 
(Table 1). 519 
 520 
Table 1. Estimated parameter values and initial conditions for the TCL within-host model [14]. 521 
Parameter Definition Value 𝛽 Infection rate of 
susceptible cells by virus 
2.7 × 10−5 (TCID50/ml)−1 
day−1 𝛿 Death rate of infected cells 4.0 day−1 
p Viral shedding rate by 
infected cells 
1.2 × 10−2 (TCID50/ml) 
day−1 
c Clearance rate of free virus 3.0 day−1 
T(0) Initial number of 
susceptible cells 
4 × 108 
I(0) Initial number of infected 
cells 
0 
V(0) Initial quantity of free virus 9.3 × 10−2 TCID50/ml 
 522 
We used the TCL model to generate synthetic data from different patients. To 523 
incorporate variability between patients, we assumed that the parameters 𝛿 and V(0) in 524 
the TCL model vary between individuals. This represents variation in the strength of the 525 
immune response and in the initial viral load. For each patient, log10(𝛿) was sampled 526 
from a normal distribution with mean 0.60 log10(day−1) and standard deviation 0.25 527 
log10(day−1), and log10(V(0)) was sampled from a normal distribution with mean −1.03 528 
log10(TCID50/ml) and standard deviation 1.12 log10(TCID50/ml). These values were 529 
chosen to match variability in previous individual parameter estimates [14], while the 530 
lognormal distribution was used to guarantee positivity. All other parameters were fixed 531 
at the values given in Table 1. 532 
 533 
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We considered analyses in which viral load was assumed to be observed exactly and 534 
continuously throughout infection, as well as analyses in which measurements of the 535 
viral load were recorded once daily for one week after infection. In the latter case, we 536 
incorporated measurement error by applying a normally distributed random variate with 537 
standard deviation 𝜎 to the logarithm of each measurement. We fitted the TCL model to 538 
the daily data from each patient using least squares estimation – in particular, the 539 
values of the parameters 𝛿 and V(0) were chosen to minimise the sum of squares 540 
distance between the logarithm of the viral load in the model and in the data, while all 541 
other parameter values were assumed to be known exactly and were fixed at the values 542 
in Table 1. To avoid unrealistically large estimates of the initial viral load, we imposed 543 
V(0) ≤ 103 TCID50/ml when we fitted the parameters. An example of synthetic data 544 
generated for a single host, in addition to the fitted TCL model, is given in figure 4a. 545 
 546 
The SInR model 547 
 548 
The population-scale SInR model [28,63] of pathogen transmission in a population of N 549 
hosts is given by 550 
𝑑𝑆𝑑𝑡 = −𝑆5𝛽!𝐼!"!#$ ,	𝑑𝐼$𝑑𝑡 = 𝑆5𝛽!𝐼! − 𝜇$𝐼$,"!#$ 	𝑑𝐼%𝑑𝑡 = 𝜇%&$𝐼%&$ − 𝜇%𝐼% , 𝑓𝑜𝑟	𝑖 = 2,… , 𝑛,	𝑑𝑅𝑑𝑡 = 𝜇"𝐼", (4.2) 
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where S(t) is the number of susceptible individuals, Ii(t) is the number of individuals in 551 
the ith infected compartment, and t days is the time since the start of the outbreak. 552 
Individuals in the ith infected compartment infect susceptible hosts at total rate 𝛽iIiS per 553 
day, and progress to the next infected compartment (or recover, if i = n) at total rate 𝜇iIi 554 
per day. The basic reproduction number of this model is [63] 555 
𝑅' = 𝑁5𝛽%𝜇%"%#$ . (4.3) 556 
 557 
From within- to between-host 558 
 559 
We used both an existing IDE approach (steps A-C below) and a new compartmental 560 
framework (steps A-B and D-E below) to transition from patient-level to population-scale 561 
dynamics. The two methods are outlined below, and a schematic is shown in figure 1. 562 
 563 
A. Fit a within-host model to longitudinally sampled data on patient-level dynamics, 564 
to estimate the pathogen load of each individual patient at every time since 565 
infection. 566 
B. Estimate the expected infectiousness curve, 𝛽(𝜏), at each time since infection, 𝜏 567 
days, by assuming that the infectiousness of each host depends on the pathogen 568 
load according to a pre-specified relationship between these quantities. 569 
Then either C: 570 
C. Solve the K&M IDE model, with infectiousness curve 𝛽(𝜏), to calculate the 571 
population-scale dynamics (details of the K&M model are given in Section S1). 572 
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Or D-E: 573 
D. Parameterise the SInR model: choose the number of infected compartments, n, 574 
where n is assumed to be large. Then find T such that 𝛽(𝜏) is zero or very small 575 
for 𝜏 > T days, and choose the parameters in the SInR model to be 576 𝜇% = 𝑛𝑇 ,	577 
𝛽% = 𝑛𝑇B 𝛽(𝜏)𝑑𝜏%( "⁄(%&$)( "⁄ , for	𝑖 = 1,… , 𝑛 − 1,	578 
𝛽" = 𝑛𝑇B 𝛽(𝜏)𝑑𝜏.,("&$)( "⁄ (4.4) 579 
Explanation of these parameter choices is given in Section S2. 580 
E. Solve the SInR model numerically to approximate the population-scale dynamics. 581 
 582 
In most of our analyses, we assumed a linear relationship between the viral load and 583 
infectiousness of each influenza-infected host, although two alternative possibilities are 584 
considered in Section S8. In particular, in our main analyses we assumed that 585 𝛽(%)(𝜏) = 𝑘𝑉(%)(𝜏), (4.5) 586 
for constant k, where i represents the particular host under consideration. Therefore, the 587 
expected infectiousness, 𝛽(𝜏), was given in terms of the expected viral load, V(𝜏), of a 588 
host at time 𝜏 days since infection (calculated over a large number of realisations of the 589 
within-host model), by 590 𝛽(𝜏) = 𝑘𝑉(𝜏). (4.6) 591 
We fixed the constant k by assuming that the basic reproduction number, 592 
𝑅' = 𝑁B 𝛽(𝜏),' 𝑑𝜏, (4.7) 593 
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was known. In our main analyses, we fixed R0 = 1.5, which is consistent with estimates 594 
for influenza A infection [8] (different values of R0 are considered in Section S9). The 595 
expected infectiousness could therefore be calculated using the formula 596 
𝛽(𝜏) = 𝑅'𝑁 ∫ 𝑉(𝑥)𝑑𝑥,' 𝑉(𝜏). (4.8) 597 
 598 
To calculate the “true” expected infectiousness curve, 𝛽(𝜏), we computed the expected 599 
viral load over 10,000 realisations of the within-host model. We also considered 600 
analyses in which data were only available from a smaller number of patients, d. In such 601 
cases, we simulated the within-host model d times to calculate the exact patient-level 602 
dynamics corresponding to each patient, and used the data to estimate first V(𝜏) and 603 
then 𝛽(𝜏). In analyses where we also incorporated measurement error, we used the 604 
patient-level dynamics estimated by fitting the within-host model to daily observations of 605 
the viral load for each patient, in order to estimate 𝛽(𝜏). 606 
 607 
Both the compartmental and IDE methods were then used to predict the population-608 
scale dynamics. To parameterise the SInR model, we took T = 7 days, since the 609 
expected infectiousness was found to be very small after a week since infection. We 610 
considered a population of size N = 1000, and assumed that there was initially a single 611 
newly infected individual, with all others susceptible. These initial conditions were 612 
implemented in the SInR model by taking I1(0) = 1 and S(0) = 999, with all other 613 
compartments containing zero hosts initially. 614 
 615 
Errors at patient-level and population-scale 616 
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 617 
We defined error metrics in order to quantify the errors that arise in the patient-level 618 
dynamics and in the population-scale dynamics. These were defined as proportional 619 
errors, so as to enable comparison between errors at the different scales. 620 
 621 
First, we defined the within-host error, Ewh, to be the difference between the exact and 622 
approximate infectiousness curves, integrated over the entire course of infection, as a 623 
proportion of the area of the exact infectiousness curve. Therefore, 624 
𝐸-. = ∫ N𝛽approx(𝜏) − 𝛽exact(𝜏)N𝑑𝜏,' ∫ 𝛽exact(𝜏)𝑑𝜏,' , (4.9) 625 
where 𝛽exact(𝜏) and 𝛽approx(𝜏) are the exact and approximate infectiousness curves, 626 
respectively. 627 
 628 
Similarly, if Sexact(t) and Sapprox(t) are the exact and approximate numbers of susceptible 629 
individuals at time t days since the start of the epidemic, then we defined the between-630 
host error, Ebh, in terms of the rate of new cases per day throughout the epidemic, i.e. 631 
𝐸7. = ∫ N?̇?approx(𝑡) − ?̇?exact(𝑡)N𝑑𝑡,' ∫ −?̇?exact(𝑡)𝑑𝑡,' , (4.10) 632 
where the dot denotes differentiation with respect to time. 633 
 634 
AUTHOR CONTRIBUTIONS 635 
RNT conceived the research; All authors designed the study; WSH carried out the 636 
research; RNT, PKM and CAY supervised the research; WSH and RNT drafted the 637 
manuscript; All authors revised the manuscript and gave final approval for publication. 638 
32 
 
 639 
ACKNOWLEDGEMENTS 640 
We would like to thank members of the Wolfson Centre for Mathematical Biology at the 641 
University of Oxford for helpful discussions about this work. We would also like to thank 642 
Nik Cunniffe for suggestions about the multi-compartment SIR model, and the 643 
anonymous reviewers whose suggestions helped us to improve the manuscript. 644 
 645 
DATA ACCESSIBILITY 646 
All analyses were performed in MATLAB. Code is available for running the models, and 647 
is available at https://github.com/will-s-hart/WithinBetweenHostCompartmental. Our 648 
approach can also be recoded and adapted straightforwardly in other computing 649 
languages. 650 
 651 
FUNDING 652 
WSH was funded by an EPSRC Excellence Award for his doctoral studies. RNT was 653 
funded by a Junior Research Fellowship from Christ Church, Oxford. The funders had 654 
no role in study design, data collection and analysis, decision to publish, or preparation 655 
of the manuscript. 656 
 657 
REFERENCES 658 
1. Coburn BJ, Wagner BG, Blower S. 2009 Modeling influenza epidemics and 659 
pandemics: insights into the future of swine flu (H1N1). BMC Med. 7, 30. 660 
2. Daszak P, Cunningham AA, Hyatt AD. 2000 Emerging infectious diseases of 661 
33 
 
wildlife---threats to biodiversity and human health. Science 287, 443–449. 662 
3. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. 663 
2008 Global trends in emerging infectious diseases. Nature 451, 990–993. 664 
4. Keeling MJ, Rohani P. 2011 Modeling infectious diseases in humans and animals. 665 
Princeton: Princeton University Press. (doi:10.1016/s1473-3099(08)70147-6) 666 
5. Morens DM, Folkers GK, Fauci AS. 2004 The challenge of emerging and re-667 
emerging infectious diseases. Nature 430, 242–249. 668 
6. Taylor LH, Latham SM, Woolhouse MEJ. 2001 Risk factors for human disease 669 
emergence. Philos. T. Roy. Soc. B 356, 983–989. 670 
7. Thompson RN, Brooks-Pollock E. 2019 Detection, forecasting and control of 671 
infectious disease epidemics: modelling outbreaks in humans, animals and plants. 672 
Philos. T. Roy. Soc. B 374. 673 
8. Fraser C et al. 2009 Pandemic potential of a strain of influenza A (H1N1): early 674 
findings. Science 324, 1557–1561. 675 
9. WHO Ebola Response Team. 2014 Ebola virus disease in West Africa - the first 9 676 
months of the epidemic and forward projections. N. Engl. J. Med. 371, 1481–95. 677 
10. Bussell EH, Dangerfield CE, Gilligan CA, Cunniffe NJ. 2019 Applying optimal 678 
control theory to complex epidemiological models to inform real-world disease 679 
management. Philos. T. Roy. Soc. B 374, 20180284. 680 
11. Ferguson NM, Donnelly CA, Anderson RM. 2001 The foot-and-mouth epidemic in 681 
Great Britain: pattern of spread and impact of interventions. Science 292, 1155–682 
1160. 683 
12. Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, 684 
34 
 
Iamsirithaworn S, Burke DS. 2005 Strategies for containing an emerging influenza 685 
pandemic in Southeast Asia. Nature 437, 209–214. 686 
13. Thompson RN, Gilligan CA, Cunniffe NJ. 2018 Control fast or control smart: when 687 
should invading pathogens be controlled? PLoS Comput. Biol. 14, 1–21. 688 
14. Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS. 2006 Kinetics 689 
of influenza A virus infection in humans. J. Virol. 80, 7590–7599. 690 
15. Canini L, Perelson AS. 2014 Viral kinetic modeling: state of the art. J. 691 
Pharmacokinet. Pharmacodyn. 41, 431–443. 692 
16. Perelson AS. 2002 Modelling viral and immune system dynamics. Nat. Rev. 693 
Immunol. 2, 28–36. 694 
17. Zitzmann C, Kaderali L. 2018 Mathematical analysis of viral replication dynamics 695 
and antiviral treatment strategies: from basic models to age-based multi-scale 696 
modeling. Front. Microbiol. 9, 1546. 697 
18. Handel A, Rohani P. 2015 Crossing the scale from within-host infection dynamics 698 
to between-host transmission fitness: a discussion of current assumptions and 699 
knowledge. Philos. T. Roy. Soc. B 370. 700 
19. Mideo N, Alizon S, Day T. 2008 Linking within- and between-host dynamics in the 701 
evolutionary epidemiology of infectious diseases. Trends Ecol. Evol. 23, 511–517. 702 
20. Hart WS, Hochfilzer LFR, Cunniffe NJ, Lee H, Nishiura H, Thompson RN. 2019 703 
Accurate forecasts of the effectiveness of interventions against Ebola may require 704 
models that account for variations in symptoms during infection. Epidemics 29, 705 
100371. 706 
21. Almocera AES, Nguyen VK, Hernandez-Vargas EA. 2018 Multiscale model 707 
35 
 
within-host and between-host for viral infectious diseases. J. Math. Biol. 77, 708 
1035–1057. 709 
22. Boldin B, Diekmann O. 2008 Superinfections can induce evolutionarily stable 710 
coexistence of pathogens. J. Math. Biol. 56, 635–672. 711 
23. Lukens S et al. 2014 A large-scale immuno-epidemiological simulation of 712 
influenza A epidemics. BMC Public Health 14, 1019. 713 
24. Lythgoe KA, Pellis L, Fraser C. 2013 Is HIV short-sighted? Insights from a 714 
multistrain nested model. Evolution 67, 2769–2782. 715 
25. Nguyen VK, Mikolajczyk R, Hernandez-Vargas EA. 2018 High-resolution 716 
epidemic simulation using within-host infection and contact data. BMC Public 717 
Health 18, 1–11. 718 
26. Yamin D, Gertler S, Ndeffo-Mbah ML, Skrip LA, Fallah M, Nyenswah TG, Altice 719 
FL, Galvani AP. 2015 Effect of Ebola progression on transmission and control in 720 
Liberia. Ann. Intern. Med. 162, 11–17. 721 
27. Coombs D, Gilchrist MA, Ball CL. 2007 Evaluating the importance of within- and 722 
between-host selection pressures on the evolution of chronic pathogens. Theor. 723 
Popul. Biol. 72, 576–591. 724 
28. Cunniffe NJ, Stutt ROJH, van den Bosch F, Gilligan CA. 2012 Time-dependent 725 
infectivity and flexible latent and infectious periods in compartmental models of 726 
plant disease. Phytopathology 102, 365–380. 727 
29. Childs LM, El Moustaid F, Gajewski Z, Kadelka S, Nikin-Beers R, Smith, Jr JW, 728 
Walker M, Johnson LR. 2019 Linked within-host and between-host models and 729 
data for infectious diseases: a systematic review. PeerJ 7, e7057. 730 
36 
 
30. Day T, Alizon S, Mideo N. 2011 Bridging scales in the evolution of infectious 731 
disease life histories: theory. Evolution 65, 3448–3461. 732 
31. Gandolfi A, Pugliese A, Sinisgalli C. 2015 Epidemic dynamics and host immune 733 
response: a nested approach. J. Math. Biol. 70, 399–435. 734 
32. Gilchrist MA, Coombs D. 2006 Evolution of virulence: interdependence, 735 
constraints, and selection using nested models. Theor. Popul. Biol. 69, 145–153. 736 
33. Handel A, Brown J, Stallknecht D, Rohani P. 2013 A multi-scale analysis of 737 
influenza A virus fitness trade-offs due to temperature-dependent virus 738 
persistence. PLoS Comput. Biol. 9. 739 
34. Legros M, Bonhoeffer S. 2016 A combined within-host and between-hosts 740 
modelling framework for the evolution of resistance to antimalarial drugs. J. R. 741 
Soc. Interface 13, 20160148. 742 
35. Murillo LN, Murillo MS, Perelson AS. 2013 Towards multiscale modeling of 743 
influenza infection. J. Theor. Biol. 332, 267–290. 744 
36. Alizon S, Van Baalen M. 2008 Acute or chronic? Within-host models with immune 745 
dynamics, infection outcome, and parasite evolution. Am. Nat. 172, E244–E256. 746 
37. Magal P, McCluskey CC, Webb GF. 2010 Lyapunov functional and global 747 
asymptotic stability for an infection-age model. Appl. Anal. 89, 1109–1140. 748 
38. Chao DL, Halloran ME, Obenchain VJ, Longini IM. 2010 FluTE, a publicly 749 
available stochastic influenza epidemic simulation model. PLoS Comput. Biol. 6. 750 
39. Canini L, Carrat F. 2011 Population modeling of influenza A/H1N1 virus kinetics 751 
and symptom dynamics. J. Virol. 85, 2764–2770. 752 
40. Vegvari C, Hadjichrysanthou C, Cauët E, Lawrence E, Cori A, De Wolf F, 753 
37 
 
Anderson RM. 2016 How can viral dynamics models inform endpoint measures in 754 
clinical trials of therapies for acute viral infections? PLoS One 11, 1–13. 755 
41. Nguyen VK, Hernandez-Vargas EA. 2017 Windows of opportunity for Ebola virus 756 
infection treatment and vaccination. Sci. Rep. 7, 8975. 757 
42. Nguyen VK, Klawonn F, Mikolajczyk R, Hernandez-Vargas EA. 2016 Analysis of 758 
practical identifiability of a viral infection model. PLoS One 11, 1–16. 759 
43. Frost S. In press. epirecipes. See http://epirecip.es/epicookbook (accessed on 11 760 
September 2019). 761 
44. Jenness SM, Goodreau SM, Morris M. 2018 Epimodel: An R package for 762 
mathematical modeling of infectious disease over networks. J. Stat. Softw. 84, 1–763 
47. 764 
45. Roberts M, Andreasen V, Lloyd A, Pellis L. 2015 Nine challenges for deterministic 765 
epidemic models. Epidemics 10, 49–53. 766 
46. Murphy BR et al. 1980 Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-767 
1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. 768 
Infect. Immun. 29, 348–355. 769 
47. Kermack WO, McKendrick AG. 1927 A contribution to the mathematical theory of 770 
epidemics. P. Roy. Soc. A 115, 700–721. 771 
48. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron 772 
AJ. 2008 Time lines of infection and disease in human influenza: a review of 773 
volunteer challenge studies. Am. J. Epidemiol. 167, 775–785. 774 
49. Lloyd AL. 2009 Sensitivity of model-based epidemiological parameter estimation 775 
to model assumptions. In Mathematical and Statistical Estimation Approaches in 776 
38 
 
Epidemiology (eds G Chowell, JM Hyman, LMA Bettencourt, C Castillo-Chavez), 777 
pp. 123–141. Dordrecht: Springer Netherlands.  778 
50. Mitchell L, Ross J V. 2016 A data-driven model for influenza transmission 779 
incorporating media effects. Roy. Soc. Open Sci. 3. 780 
51. Wearing HJ, Rohani P, Keeling MJ. 2005 Appropriate models for the 781 
management of infectious diseases. PLoS Med. 2, 0621–0627. 782 
52. Blythe SP, Anderson RM. 1988 Distributed incubation and infectious periods in 783 
models of the transmission dynamics of the Human Immunodeficiency Virus 784 
(HIV). Math. Med. Biol. 5, 1–19. 785 
53. Lloyd AL. 2001 Destabilization of epidemic models with the inclusion of realistic 786 
distributions of infectious periods. P. Roy. Soc. B 268, 985–993. 787 
54. Hethcote HW, Van Ark JW, Longini IM. 1991 A simulation model of AIDS in San 788 
Francisco: I. Model formulation and parameter estimation. Math. Biosci. 106, 203–789 
222. 790 
55. Christofferson RC, Mores CN, Wearing HJ. 2014 Characterizing the likelihood of 791 
dengue emergence and detection in naïve populations. Parasites and Vectors 7, 792 
282. 793 
56. Beauchemin CAA, Handel A. 2011 A review of mathematical models of influenza 794 
A infections within a host or cell culture: lessons learned and challenges ahead. 795 
BMC Public Health 11, S7. 796 
57. Nishiura H, Eichner M. 2007 Infectiousness of smallpox relative to disease age: 797 
estimates based on transmission network and incubation period. Epidemiol. 798 
Infect. 135, 1145–1150. 799 
39 
 
58. Best K, Guedj J, Madelain V, de Lamballerie X, Lim S-Y, Osuna CE, Whitney JB, 800 
Perelson AS. 2017 Zika plasma viral dynamics in nonhuman primates provides 801 
insights into early infection and antiviral strategies. P. Natl. Acad. Sci. USA 114, 802 
8847–8852. 803 
59. Thompson RN, Wymant C, Spriggs RA, Raghwani J, Fraser C, Lythgoe KA. 2019 804 
Link between the numbers of particles and variants founding new HIV-1 infections 805 
depends on the timing of transmission. Virus Evol. 5. 806 
60. Fraser C. 2007 Estimating individual and household reproduction numbers in an 807 
emerging epidemic. PLoS One 2. 808 
61. Hernandez-Vargas EA et al. 2014 Effects of aging on influenza virus infection 809 
dynamics. J. Virol. 88, 4123–4131. 810 
62. Smith AM, Perelson AS. 2011 Influenza A virus infection kinetics: quantitative 811 
data and models. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 812 
3, 429–445. 813 
63. Allen LJS, Lahodny GE. 2012 Extinction thresholds in deterministic and stochastic 814 
epidemic models. J. Biol. Dyn. 6, 590–611. 815 
 816 
